Qianhai Health Holdings Limited (HKG:0911)

Qianhai Health Holdings Statistics

Total Valuation

HKG:0911 has a market cap or net worth of HKD 49.14 million. The enterprise value is 22.44 million.

Market Cap	49.14M
Enterprise Value	22.44M

Important Dates

The next estimated earnings date is Tuesday, March 24, 2026.

Earnings Date	Mar 24, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:0911 has 169.45 million shares outstanding.

Current Share Class	169.45M
Shares Outstanding	169.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	80.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.09
PB Ratio	0.13
P/TBV Ratio	0.13
P/FCF Ratio	1.95
P/OCF Ratio	1.95
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.37
EV / Sales	0.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.89

Financial Position

The company has a current ratio of 196.24, with a Debt / Equity ratio of 0.00.

Current Ratio	196.24
Quick Ratio	129.44
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	0.03
Interest Coverage	-438.39

Financial Efficiency

Return on equity (ROE) is -2.40% and return on invested capital (ROIC) is -4.59%.

Return on Equity (ROE)	-2.40%
Return on Assets (ROA)	-2.27%
Return on Invested Capital (ROIC)	-4.59%
Return on Capital Employed (ROCE)	-4.27%
Weighted Average Cost of Capital (WACC)	4.70%
Revenue Per Employee	39.54M
Profits Per Employee	-675,929
Employee Count	14
Asset Turnover	1.21
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.83% in the last 52 weeks. The beta is 0.08, so HKG:0911's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+20.83%
50-Day Moving Average	0.27
200-Day Moving Average	0.26
Relative Strength Index (RSI)	69.84
Average Volume (20 Days)	45,011

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:0911 had revenue of HKD 553.58 million and -9.46 million in losses. Loss per share was -0.06.

Revenue	553.58M
Gross Profit	929,000
Operating Income	-16.66M
Pretax Income	-9.46M
Net Income	-9.46M
EBITDA	-15.30M
EBIT	-16.66M
Loss Per Share	-0.06

Balance Sheet

The company has 27.43 million in cash and 733,000 in debt, with a net cash position of 26.70 million or 0.16 per share.

Cash & Cash Equivalents	27.43M
Total Debt	733,000
Net Cash	26.70M
Net Cash Per Share	0.16
Equity (Book Value)	390.07M
Book Value Per Share	2.30
Working Capital	370.18M

Cash Flow

In the last 12 months, operating cash flow was 25.22 million and capital expenditures -10,000, giving a free cash flow of 25.21 million.

Operating Cash Flow	25.22M
Capital Expenditures	-10,000
Free Cash Flow	25.21M
FCF Per Share	0.15

Margins

Gross margin is 0.17%, with operating and profit margins of -3.01% and -1.71%.

Gross Margin	0.17%
Operating Margin	-3.01%
Pretax Margin	-1.71%
Profit Margin	-1.71%
EBITDA Margin	-2.76%
EBIT Margin	-3.01%
FCF Margin	4.55%

Dividends & Yields

HKG:0911 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-19.26%
FCF Yield	51.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 20, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	May 20, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

HKG:0911 has an Altman Z-Score of 15.06 and a Piotroski F-Score of 4.

Altman Z-Score	15.06
Piotroski F-Score	4